Pages AbbVie v. Amgen Amgen v. Apotex Amgen v. Hospira Amgen v. Sandoz – D.N.J. Amgen v. Sandoz – N.D. Cal. Appeals BPCIA Litigation Summary Chart BPCIA Litigation PTAB Tracker…
…to CT-P17 up to week 52.” In the same press release, Celltrion also announced that the European Commission has granted marketing authorization for Celltrion’s subcutaneous infliximab biosimilar, Remsima™ SC (CT-P13…
…AstraZeneca, and Janssen. Ms. Cooke recently recognized three historical figures in celebration of International Women’s Day: Gerty Cori, who discovered the lactic acid cycle (also known as the Cori cycle)…
…volume, citrate-free adalimumab biosimilar YuflymaTM (CT-P17) on February 15. According to Celltrion, YuflymaTM will be priced similarly to other biosimilars of adalimumab, potentially giving Celltrion an advantage in pricing and…
On February 15, 2021, Celltrion Healthcare announced that the European Commission granted marketing authorization for Yuflyma™ (CT-P17), an adalimumab biosimilar, on February 11, 2021. Yuflyma™ was approved across all thirteen…
Celltrion Inc. has begun a Phase 3 clinical trial of CT-P42, an aflibercept biosimilar referencing Regeneron’s Eylea. The trial will enroll 300 patients with diabetic macular edema, and aims to…
Celltrion Healthcare Canada Limited announced yesterday that Health Canada granted a notice of compliance for Remsima SC®, an infliximab biosimilar of J& J’s Remicade®, for the treatment of adult patients…
…Iceland’s Biotechnology Department.” Celltrion closed out its year announcing plans for a global phase 3 clinical trial of its ustekinumab biosimilar (CT-P43), aiming to complete the confirmation of CT-P43’s safety…
…HoUng Kim, Head of Medical and Marketing Division at Celltrion Healthcare, said that if the product is approved, “Celltrion will be the first company to introduce an adalimumab biosimilar with…
…The plant will allow Celltrion to increase its production capacity from 190,000 liters per year to 250,000 liter per year. A Celltrion official stated that “[w]ith the construction of the…